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and intra-host variant frequencies
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Abstract
Intra-host single nucleotide variants (iSNVs) have been increasingly used in genomic epidemiology to increase phylogenetic
resolution and reconstruct fine-scale outbreak dynamics. These analyses are preferably done on sequence data from direct
clinical samples, but in many cases due to low viral loads, there might not be enough genetic material for deep sequencing and
iSNV determination. Isolation of the virus from clinical samples with low-passage number increases viral load, but few studies
have investigated how dengue virus (DENV) culture isolation from a clinical sample impacts the consensus sequence and the
intra-host virus population frequencies. In this study, we investigate consensus and iSNV frequency differences between DENV
sequenced directly from clinical samples and their corresponding low-passage isolates. Twenty five DENV1 and DENV2 positive sera and their corresponding viral isolates (T. splendens inoculation and C6/36 passage) were obtained from a prospective
cohort study in the Philippines. These were sequenced on MiSeq with minimum nucleotide depth of coverage of 500×, and
iSNVs were detected using LoFreq. For both DENV1 and DENV2, we found a maximum of one consensus nucleotide difference
between clinical sample and isolate. Interestingly, we found that iSNVs with frequencies ≥5 % were often preserved between
the samples, and that the number of iSNV positions, and sample diversity, at this frequency cutoff did not differ significantly
between the sample pairs (clinical sample and isolate) in either DENV1 or DENV2 data. Our results show that low-passage
DENV isolate consensus genomes are largely representative of their direct sample parental viruses, and that low-passage
isolates often mirror high frequency within-host variants from direct samples.

has four serotypes, DENV1, 2, 3 and 4. DENV consists of a
genome approximately 11 kb nucleotides (nt) in length. The
genome encodes three structural proteins, nucleocapsid (C),
precursor membrane (prM) and envelope (E), as well as seven
nonstructural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B,
and NS5) [1, 2].

INTRODUCTION
Dengue virus (DENV) is the etiologic agent of dengue fever
(DF) as well as the more severe forms of illness, dengue
haemorrhagic fever (DHF) and dengue shock syndrome
(DSS), which cause significant health problems each year.
Approximately 50–100 million symptomatic DENV infections occur each year, with the greatest burden in tropical and
subtropical regions. DENV is an arbovirus, a mosquito-borne
RNA virus commonly transmitted by Aedes mosquitoes. It
belongs to the Flavivirus genus of the Flaviviridae family and

Viral genome sequence data, including that of DENV, have
increasingly been used in epidemics and outbreaks to provide
more precise reconstructions of transmission dynamics and
complement conventional non-genomic epidemiologic data.
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In addition to the lack of knowledge on how DENV isolation from a clinical sample impacts the consensus sequence,
there is no information on how the intra-host virus population may change with isolation and passaging. This information is scarce for arboviruses in general. Stapleford et al.
compared Chikungunya virus (CHIKV) iSNVs in isolate
samples, with single passage in mammalian or vector cell
lines, with iSNVs in viruses from direct clinical samples
[13]. They found that the high-frequency iSNVs were maintained over passaging. However, they also noted a decrease
in overall diversity, with more diversity maintained when
passaging one time through mammalian cells rather than
vector cells. No such studies have been performed on
DENV.

This approach of genomic epidemiology for DENV has played
a crucial role in analyses of spatial and temporal outbreak
dynamics, virus dispersal tracking, genotype-
phenotype
associations, vaccine effectiveness, vector adaptation and
many others [3–5]. Generally, genomic epidemiology studies
analyse DENV consensus genomes derived from each host.
However, DENV and other RNA viruses exist within a host as
a population of intra-host variants, not as a single consensus
genome. Advanced next-generation sequencing (NGS) technology can now detect intra-host viral variants present at low
frequencies within a sample. Increasingly, the importance of
these intra-host single nucleotide variants (iSNVs), and the
amount of diversity they create within a host, has been highlighted in recent studies. For instance, Ko et al. described the
presence and emergence of DENV intra-host variants with
differing selection advantages affecting epidemic severity,
and Descloux et al. suggested a correlation of DENV within-
host diversity with disease severity [6, 7]. iSNVs have also
been used for more precise tracking of viral transmission
and spread within outbreaks and epidemics, providing more
granular information on transmission chains and possible
hotspots of viral dissemination [8, 9].

Because of the importance of accurate DENV consensus
genomic data from a range of dengue case viral loads,
as well as accurate estimations of the intra-host populations and minor variants, we sought to compare DENV
consensus sequences from direct clinical samples (sera)
to low-passage isolates derived from the same samples. In
addition, we compare iSNV (minor variant) frequencies
in DENV sequencing both in direct samples and their
corresponding isolate genomes. This provides information on the possible consensus changes low-passaging of
DENV from direct clinical samples might induce, as well
as any changes in the frequency of intra-host population
variants. Since low-passaged DENV isolates are frequently
and increasingly used in investigations of DENV diversity
and spread, this study provides important insight into the
effect of passaging on the DENV genome sequence.

NGS of within-host viral populations is preferably done
directly on clinical samples, such as blood, serum, nasopharyngeal swabs or saliva, cerebro-spinal fluid and others.
However, in many cases, clinical samples may have low viral
loads, thus not providing enough genetic material for deep
sequencing and complete genome reconstruction with high
depth of coverage, requirements that are needed for analyses
of low-frequency variants within a sample. This creates bias in
some DENV genomic epidemiological investigations as low-
viremic individuals are excluded from genomic analysis yet
likely play a major role in DENV epidemic dynamics [5, 10].

METHODS
Specimen collection and viral passaging
Eleven DENV1 culture-
positive sera and their corresponding isolates, and 14 DENV2 culture-positive sera and
their corresponding isolates, were received from the Armed
Forces Research Institute of Medical Sciences (AFRIMS).
These specimens were collected between 2012 and 2015
from a prospective cohort study of incident dengue illness
set in Cebu, the Philippines (WRAIR no. 1844). The
isolates had been passaged as follows: undiluted plasma/
serum (0.34 µl/mosquito) was inoculated in 10–20 Toxorhynchitis splendens mosquitoes. Amplification of virus in
mosquitoes was assessed by an immunofluorescence assay
(IFA) assay on head squash preparations. The bodies of IFA-
positive mosquitoes were macerated and inoculated onto
C6/36 cells. Following one passage, the virus was serotyped,
aliquoted and stored at −70 °C or below.

An alternative approach is to isolate the virus from clinical
samples in cell culture and passage it a low number of times
(typically less than three passages) in order to amplify the
virus thereby allowing an increase in sequencing depth
of coverage. Generally, it is thought that isolation and
low-passaging does not change the consensus sequence
of the virus. For instance, Vasilakis et al. investigated
how passaging affects the consensus sequence of DENV,
and although they did not compare direct clinical sample
sequence to the sequence of the passaged isolates, they
showed that passaging of isolates many times (n=5 or n=10)
results in change of the virus consensus sequence while
low-passage number (n=2) does not [11]. They suggested
that these changes are most probably not due to a passaging
bottleneck, but rather adaptation to cells. Importantly, they
also showed that fewer passaging-induced consensus mutations are found in viruses passaged through C6/36 cells
(Aedes albopictus vector) compared to passaging in human
cell lines or vector-human alternating cell lines. Likewise,
Chen et al. showed an increasing number of mutations in
DENV consensus sequences with the increased number of
isolate passages (n=20, 30) [12]. However, no studies to date
have compared how the sequence of DENV virus from a
direct clinical sample may change due to passaging.

Virus sequencing
200 ul of each clinical specimen and corresponding cultured
isolate was used for RNA extraction with QIAamp Viral
RNA Mini Kit (Qiagen, MD, USA). Full DENV genomes
were amplified via Access Array (AA) system (Fluidigm
Corporation, CA, USA) using 48 pairs of in-house DENV
serotype-specific primers and the SuperScript III One-Step
2
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Table 1. Number of consensus differences and positions with iSNVs per DENV1 genome from direct samples and their corresponding isolates
Sample name

iSNVs ≥5 % direct sample

iSNVs ≥5 % isolate

iSNVs ≥1 % direct sample

iSNVs ≥1 % isolate

Consensus differences*

AB204803_D1_1

0

0

3

5

0

AB204803_D1_2

3

4

8

9

0

AB204803_D1_3

8

3

41†

7

0

AB204803_D1_4

2

1

5

2

0

AB204803_D1_5

0

0

6

4

0

AB204803_D1_6

1

1

5

7

0

AB204803_D1_7

1

1

6

2

0

AB204803_D1_8

3

3

4

6

0

AB204803_D1_9

0

19†

na

na

0

AB204803_D1_10

1

0

2

5

1

AB204803_D1_11

1

na

na

na

na

na, Not assembled.
*Not including iSNV positions.
†Outlier sample.

RT-PCR system with Platinum Taq High Fidelity polymerase (ThermoFisher Scientific, MA, USA), and 35 cycles,
followed by cDNA purification using Agencourt AMPure
XP beads (Beckman Coulter, CA, USA). The PCR products
were analysed using High Sensitivity DNA D5000 tapes
(Agilent Technologies, CA, USA) on the Agilent Tapestation 4200 System (Agilent Technologies) to check cDNA
quality and quantity. The NGS libraries were prepared using
QIAseq FX DNA Library kit (Qiagen) following the manufacturer’s instructions. Then, 50 ng per sample of amplified
amplicon was used as input DNA for library preparation.
The input DNA was fragmented for 15 min and amplified
six cycles. The purified indexed libraries were quantified
with Agilent Tapestation using DNA D5000 tapes (Agilent).
Equal molar quantities of libraries were pooled based on
the Tapestation data. Pooled libraries were denatured and
diluted to a final loading concentration of 11.5pM and
loaded onto the Miseq sequencing reagent cartridge from
Miseq Reagent kit v3, 600 cycles, (illumina, CA, USA) for
sequencing.

pipeline, NGS_Mapper that includes the variant caller
LoFreq [14, 15]. Briefly, the default setting of 5/95 was
used for the NGS_Mapper calling of intra-host nucleotide
variants, allowing for analyses of variant frequencies per
nucleotide position down to 5 %. In addition, we performed
a separate analysis of variants present in the population at
a frequency 1 % or higher. The minimum nucleotide Phred
score threshold was set to 30. This means that any site
containing a variant nucleotide of quality score greater than
30 and present at, or greater than, 5 or 1 % would be annotated as an ambiguous position. In addition, the minimum
depth of coverage to detect a variants was set to 500×. The
consensus genomes were quality checked and manually
curated using IGV and Geneious version R10, as well as
each sample’s VCF file for statistical support [16–18]. This
post-assembly cleaning process of the final consensus was
implemented to ensure removal of any nucleotide variants
present due to primer-induced error (variants only occurring in the known primer regions and only found at the
ends of the reads), certain types of sequencing error, and
strand bias higher than what was observed in confident
calls from each genome, respectively. In addition, minor
nucleotide variants that were consistently present at either
ends of the reads were manually removed from the analyses,
as these have previously been shown to be spurious [19]. All
genomes have been submitted to GenBank under accession
numbers MT832032–MT832080. Shannon entropy was

Virus genome assembly and variant calling
DENV reads from each sample were mapped to one of
four references: one DENV1 reference (AB204803) and
three DENV2 references (KU509277, KM279601 and
KU517847), which were determined by first mapping
the sequenced samples to a concatenated reference file
containing numerous DENV1 and DENV2 genomes with
location listed as Philippines and year 2012 to 2015 from
GenBank. Using mapping output to support the best-
fitting reference for each sample, the sequenced samples
were mapped again individually to one of the four references. For the mapping and analysis, we used an in-house

H′ = −

n
( )
∑
fi lnfi

i=1
calculated for each sample using 
, where
fi is the observed frequency of an iSNV, and adjusting for
genome length of 10 179 nucleotides for DENV1 and 10 176
nucleotides for DENV2.
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Table 2. DENV1 iSNV CDS positions for ≥5 % data, and their variant frequencies for samples mapped to reference AB204803
Sample

CDS nt position

Direct genome nt [AA]

Isolate genome nt [AA]

1206

G[V]95 % A[V]=5 %

G[V]=94 % A[V]=6 %

1323

T[T]>95 %*

T[T]=93 % C[T]=7 %

2134

G[V]=86 % A[M]=14 %

G[V]=88 % A[M]=12 %

8829

C[V]=37 % T[V]=63 %

C[V]=39 % T[V]=61 %

66

T[R]=6 %; C[R]=94 %

T[R]>95 %

844

A[R]=72 %; C[R]=28 %

A[R]>95 %

1806

G[V]=86 %; A[V]=14 %

G[V]=93 %; A[V]=14 %

1809

A[Q]=88 %; G[Q]=12 %

A[Q]=92 %; G[Q]=18 %

1962

G[K]=81 %; T[K]=19 %

G[K]>95 %

2061

C[R]=76 %; T[R]=24 %

C[R]>95 %

3016

C[L]=75 % T[L]=25 %

C[L]=81 % T[L]=19 %

6761

G[R]=39 % A[K]=61 %

A[K]>95 %

5442

G[E]=6 % C[D]=94 %

C[D]=>95 %

8310

C[G]=95 % A[G]=5 %

C[G]=95 % A[G]=5 %

AB204803_D1_6

8628

C[F]=19 % T[F]=81 %

C[F]=18 % T[F]=82 %

AB204803_D1_7

1655

C[T]=60 % T[M]=40 %

C[T]=60 % T[M]=40 %

AB204803_D1_8

3512

C[T]=29 % T[I]=71 %

C[T]=19 % T[I]=81 %

6750

G[L]=51 % A[L]=49 %

G[L]=42 % A[L]=58 %

9261

A[R]=89 % G[R]=11 %

A[R]=88 % G[R]=12 %

3306

T[D]=14 %; C[D]=86 %

C[D]>95 %

AB204803_D1_2

AB204803_D1_3

AB204803_D1_4

AB204803_D1_10

AA, amino acid; nt, nucleotide.
*Minor variants were present, albeit at a frequency <5 %.

already at 5 % level cutoff and was deemed an outlier, pointing
to possible contamination of this sample (Table 1). Thus, nine
DENV1 samples were used for DENV1 iSNV comparisons
between viruses sequenced directly from clinical samples and
their corresponding cultured isolates. For 5 % cutoff analyses,
two of the samples did not have any iSNV positions in the
genomes derived from either the direct sample or the cultured
virus (Table 1). For genomes from direct samples, the average
number of iSNV positions was 2.1 (range 0–8) per genome
(Table 1). For genomes from their corresponding isolates, the
average number of iSNV positions was 1.4 (range 0–4) per
genome (Table 1) and it did not differ significantly from the
number of iSNV positions in the direct samples (P >0.05, f-
test). On the 1 % variant frequency cutoff level, one additional
direct sample (AB204803_D1_3) was found to be an outlier
containing 33 iSNV positions. However, since this sample was
included in the 5 % analyses, we performed statistical analyses
for the 1 % data both including and excluding this sample.
Excluding this outlier, the average number of iSNV positions
was 4.9 (range 2–8) for the direct samples and 5.0 (range 2–9)
for their isolates, not differing statistically (P >0.05). Including

RESULTS
Full genomes were obtained for all 11 DENV1 viruses derived
from the direct clinical samples and for 10 of their corresponding virus isolates (T. splendens inoculation followed
by one C6/36 passage). Full genomes were obtained from 14
DENV2 viruses derived from the direct clinical samples and
from all of their corresponding virus isolates (T. splendens
inoculation followed by one C6/36 passage). The overall depth
of genome coverage for all obtained sequences was >500×
throughout the genome, and positions with intra-host Single
Nucleotide Variants (iSNVs) were scanned for. Variants
present at a frequency of 5 % or higher, and 1 % or higher,
were called based on criteria described in Methods.

DENV1 consensus and iSNVs in direct sample
versus corresponding culture
Of 22 DENV1 samples (11 direct-culture pairs), one genome,
from the AB204803_D1_11 cultured virus, was not assembled.
All except one direct-culture pair had identical consensus
genomes (Table 1). One genome, from the AB204803_D1_9
cultured virus, contained an unusual number of iSNV positions
4
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Table 3. Number of consensus differences and positions with iSNVs per DENV2 genome from direct samples and their corresponding isolates
Sample name

iSNVs ≥5 % direct sample

iSNVs ≥5 % isolate

iSNVs ≥1 % direct sample

iSNVs ≥1 % isolate

Consensus differences*

KU509277_D2_1

3

3

5

3

0

KU509277_D2_2

3

3

6

6

0

KU509277_D2_3

2

2

33

3

0

KU517847_D2_1

5

3

17

7

0

KM279601_D2_1

10

6

81†

9

1

KM279601_D2_2

5

2

42

2

1

KM279601_D2_3

3

1

12

1

1

KM279601_D2_4

5

3

15

9

1

KM279601_D2_5

4

5

26

6

1

KM279601_D2_6

1

3

3

3

0

KM279601_D2_7

1

0

22

1

0

KM279601_D2_8

2

2

2

2

0

KM279601_D2_9

4

4

9

6

0

KM279601_D2_10

1

2

9

6

1

*Not including iSNV positions.
†Outlier sample.

the outlier, the average number of iSNV positions was 8.9
(range 1–41) for the direct samples, making the number of
iSNVs significantly higher for the direct samples (P <0.05).

DENV2 consensus and iSNVs in direct sample
versus corresponding culture
Of 28 DENV2 samples (14 direct-culture pairs), all genomes
were available for consensus and iSNV comparisons between
clinical samples and their corresponding cultured viruses.
There were 0–1 consensus genome differences found between
the sample pairs (Table 3). For the 5 % variant frequency
cutoff level, the average number of iSNV positions was 3.5
(range 1–10) for direct samples. For genomes from their
corresponding isolates, the average number of iSNV positions was 2.8 (range 0–6) per genome (Table 3). The number
of iSNV positions did not differ significantly between direct
samples and their isolates (P >0.05, f-test). On the 1 %
variant frequency cutoff level, one additional direct sample
(KM279601_D2_1) was found to be outlier containing 81
iSNV positions. However, since this sample was included in
the 5 % analyses, we performed statistical analyses for the 1 %
data both including and excluding this sample. Excluding this
outlier, the average number of iSNV positions was 15.5 (range
2–42) for the direct samples and 4.2 (range 0–9) for their
isolates, differing statistically (P <0.05). Including the outlier,
the average number of iSNV positions was 20.1 (range 2–81)
for the direct samples and 4.6 (range 1–9) for the isolates, also
significantly different (P <0.05).

We compared the positions with iSNVs, and variant frequencies within those positions, between the genomes from DENV
1 direct samples and their corresponding cultures, at both 5
and 1 % variant frequency cutoffs. For the variant frequency
cutoff of 5 %, we found that many iSNV positions overlapped
between the direct sample and isolate viral populations
(Table 2). Out of a total of 19 positions with iSNVs in the
clinical DENV1 samples, 12 were also present in their isolates.
Isolate samples had a total of 13 iSNV positions of which 12
were also found in the clinical samples. (Table 2). In eight
of the positions, a minor variant present at the frequency of
≥5 % was found exclusively in either the direct sample or the
isolate genome. Interestingly, some of these positions were
confirmed to actually contain the corresponding variants,
albeit at frequencies <5 % (Table S1, available in the online
version of this article). The iSNV position overlap between
direct sample and its isolate was less frequent for variants
occurring at a frequency 1–5 % (Table S1).
Shannon entropy was calculated to measure the amount of
diversity within each sample. The entropy did not significantly
differ between direct samples and isolates at 5 % frequency
cutoff (P >0.05)(Fig. S1). At 1 % frequency cutoff, the Shannon
entropy was significantly higher for the direct samples
(P=0.01), however, when the AB204803_D1_3 outlier was
removed from the calculation, the Shannon entropy was not
different between direct samples and their isolates (P >0.05)
(Fig. S1).

We compared the positions with iSNVs, and variant
frequencies within those positions, at both 5 and 1% variant
frequency cutoffs, for the genomes from DENV2 direct
samples and their corresponding cultures (Tables 4, S2 and
S3). For 5 % cutoff, 24 of 49 direct sample iSNV positions were
also found in the isolates, and 24 of 39 isolate iSNV positions
5
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Table 4. DENV2 iSNV CDS positions and their variant frequencies, for ≥5 % data, for samples mapped to references KU509277 or KU517847
Sample
KU509277_D2_1

KU509277_D2_2

KU509277_D2_3

KU517847_D2_1

CDS nt position

Direct genome

Isolate genome

2995

T[T]=5 %; C[T]=95 %

C[T]>95 %

4056

T[A]=72 % C[A]=28 %

T[A]=72 % C[A]=28 %

8085

T[A]=72 % C[A]=28 %

T[A]=76 % C[A]=24 %

8308

A[K]>95 %

G[K]=5 %; A[K]=95 %

1014

G[K]=72 % A[K]=28 %

G[K]=86 % A[K]=14 %

2338

G[V]=91 % A[I]=10 %

G[V]=93 % A[I]=7 %

4374

A[S]=91 % G[S]=9 %

A[S]=94 % G[S]=6 %

1059

C[R]=>95 %*

C[R]=94 % A[R]=6 %

1098

G[Q]=95 % A[Q]=5 %

G[Q]=>95 %

8642

C[T]=84 % T[I]=16 %

C[T]=82 % T[I]=18 %

512

A[N]=5 %; G[D]=95 %

A[N]=5 %; G[D]=95 %

4617

G[R]=6 %; A[R]=94 %

G[R]=5 %; A[R]=95 %

4959

T[I]=15 % A[I]=85 %

T[I]=12 % A[I]=88 %

6128

G[R]=6 %; A[K]=94 %

A[K]>95 %*

7591

C[L]=6 %; T[L]=94 %

T[L]>95 %

nt, nucleotide; AA, amino acid.
*Minor variants were present, albeit at a frequency <5 %.

were also confirmed in the direct samples. As for DENV1, we
observed DENV2 positions with a minor variant present at
the frequency of ≥5 % found exclusively in either the direct
sample or the isolate genome, however, some of these positions did have variants below 5 % frequency.

transmission chains [6–9]. For such studies, sequencing of
viral genomes from clinical samples is ideal, however, the
amount of genetic material may not be sufficient to achieve
depth that is required for iSNV identification and analysis.
Therefore, viruses from clinical samples may be amplified
in cell culture, to achieve sufficient nucleic acid yields for
primary analysis, as well as to preserve the virus for additional studies. Often, research reviews highlight sequencing of
isolates as a limitation to direct sequencing of clinical samples,
despite a relative absence of data showing passaged viruses
having a different consensus sequence to its clinical parent.
In this study we aimed to investigate whether low-passaging
can change DENV genome consensus sequence, or the minor
variant admixture, compared to a direct clinical specimen.

At 5 % level, there were no significant differences between
DENV1 and DENV2 in the number of iSNV positions per
genome in either direct or isolate samples (P >0.05). Similarly to the results for DENV1, the iSNV position overlap
between direct sample and its isolate was less frequent for
DENV2 variants occurring at a frequency 1–5 % (Table S3).
Shannon entropy was calculated to measure the amount of
diversity within each sample. The entropy did not significantly
differ between direct samples and isolates (including the
KM279601_D2_1 outlier) at 5 % frequency cutoff, but was
significant at the 1 % frequency cutoff (Fig. S2).

We compared virus from direct clinical samples and their
corresponding cultured viruses for both DENV1 and DENV2,
and found that there were no significant differences in the
number of iSNV positions, or in the Shannon entropy,
between the sample pairs (direct and isolate) when looking
at variants present at 5 % or higher. This diversity preservation
was also true when variant frequency cutoff was 1 % upon
removal of outlier sample for DENV1, but not for DENV2.
This suggests there was no increase or decrease in ≥5 % iSNV
diversity following amplification of DENV through T. splendens inoculation and one C6/36 passage, however, the isolate
diversity did decrease for DENV2 when including variants at
frequencies 1–5 %. These results are mainly in concordance
with a previous study showing that the amount of dengue

DISCUSSION
Genomic epidemiology is increasingly being used in dengue
and other viral outbreaks to provide complementary insights
into viral transmission and epidemic dynamics [4, 20].
Such information can be used for more precise tracking
of viral transmission and locating possible hotspots of
viral dissemination. However, consensus genomes provide
limited epidemiological inference, particularly when sampled
from infected cases closely linked in space and time [5]. To
circumvent this problem and increase resolution, iSNVs have
recently been used for more precise reconstructions of virus
6

Fung et al., Journal of General Virology 2021;102:001553

intra-host diversity generally does not change when the virus
is transmitted from human to mosquito [21]. Also in concordance with previous human–mosquito transmission studies,
we found that DENV iSNVs occurring at higher frequencies (≥5 %) were often preserved after mosquito and C6/36
culture passage [13, 21], although instances with iSNVs that
were exclusive to either direct samples or cultured samples
were observed. This was more pronounced when looking
at variants present at lower frequencies (1 –5 %), suggesting
that like in human–mosquito transmission, virus isolation
may result in removal of low-frequency variants, followed
by eventual restoration of diversity upon virus replication in
culture, albeit with a different low-frequency iSNV repertoire.
The lower diversity at 1 % cutoff in DENV2 isolate samples
might mirror this purge of low-frequency minor variants
from direct samples, where the iSNV repertoire had not been
restored yet. The discrepant results between DENV1 and
DENV2 diversity at 1 % variant frequency cutoff may be due
to differences between the two serotypes, or may be that the
threshold for low-frequency iSNV restoration is somewhere
between 1–2 passages. This becomes important to consider in
studies utilizing within-host variation for more precise transmission inferences. However, we show that higher frequency
iSNVs (≥5 %) were often preserved, and if these are found in
low-passage isolates from epidemiologically linked cases, they
may represent true instances of minor variant transmission.

previously constrained by dengue case viral load. Our results
serve as an important technical reference for DENV genomic
epidemiology, virus dispersal tracking and vaccine effectiveness studies.
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